Incyte

The Zacks Analyst Blog Highlights: Incyte, Celldex, Bristol-Myers, AstraZeneca and Halozyme
Yahoo/Zacks.com
Thu, 05/22/14 - 08:36 am
Incyte
Celldex
Bristol-Myers Squibb
AstraZeneca
Halozyme
AstraZeneca and Incyte to study cancer drugs together
Yahoo/Reuters
Wed, 05/14/14 - 08:18 am
AstraZeneca
Incyte
cancer
R&D
Show me the money: Which drugs made the top 10 list on upfront deals?
Fierce Biotech
Mon, 05/12/14 - 09:36 am
biotech
GED-0301
Celgene
Nogra Pharma
AbbVie
Reata
Bardoxolone
Abbott Labs
Tradjenta
Eli Lilly
Boehringer Ingelheim
FG-4592
AstraZeneca
FibroGen
Pfizer
Bristol-Myers Squibb
Eliquis
Moderna
Forma Therapeutics
dimebon
Medivation
Jakafi
Novartis
Incyte
Gilead: X-Marks The Spot For Sovaldi Sales
Seeking Alpha
Wed, 04/23/14 - 10:18 am
Gilead Sciences
Sovaldi
hepatitis C
Incyte
Clovis Oncology
Puma Biotechnology
Does This Stock Warrant a $9 Billion Market Cap?
Motley Fool
Sat, 03/29/14 - 09:11 am
Incyte
Incyte May Be Undervalued Even After Rise, New CEO Says
Bloomberg
Sat, 02/22/14 - 10:49 am
Incyte
Incyte's new CEO says his pipeline is underrated--and undervalued
Fierce Biotech
Fri, 02/21/14 - 09:36 am
Incyte
Pharma CEOs
Hervé Hoppenot
Incyte Shows Its Path Towards Growth
Seeking Alpha
Thu, 02/13/14 - 09:31 am
Incyte
Jakafi
Frantic Pace In Cancer Immunotherapy: Merck Vs. Bristol-Myers
Seeking Alpha
Wed, 02/12/14 - 09:14 am
cancer immunotherapy
Merck
Bristol-Myers Squibb
Amgen
Incyte
Pfizer
MK-3475
Ablynx
Yervoy
Merck Accelerates Cancer-Immunotherapy Program With Three Collaborations
TheStreet.com
Wed, 02/5/14 - 08:42 am
cancer immunotherapy
Merck
Amgen
Incyte
Pfizer
Bristol-Myers Squibb
MK-3475
Novartis Oncology chief Hoppenot leaps to the CEO job at partner Incyte
Fierce Pharma
Tue, 01/14/14 - 09:17 am
Novartis
Incyte
pharmaceutical executives
UBS Has Nine Biotech Buyout and Merger Candidates
24/7 Wall St
Tue, 01/14/14 - 09:07 am
biotech
M&A
Alexion
Biomarin
Incyte
Medivation
Idenix
Insmed
InterMune
Puma Biotechnology
Vertex Pharmaceuticals
The J.P. Morgan Healthcare Confab Monday Morning News Dump
TheStreet.com
Mon, 01/13/14 - 10:12 am
JPMHC 2014
GSK
Intercept Pharma
Acorda Therapeutics
Cell Therapeutics
Novartis
Sanofi
Alnylam
Idenix
Alexion
Galena Biopharma
Incyte
Clovis Oncology
Dendreon
Merck
Arena Pharmaceuticals
What’s Next for Biotech?
Barron's
Fri, 01/10/14 - 06:47 pm
Celgene
Alexion
Incyte
Biomarin
Why Did These 3 Biotechs Fail to Rally?
Motley Fool
Mon, 12/2/13 - 04:57 pm
Incyte
Questcor Pharmaceuticals
Acthar
Techne
Multiple Reasons To Buy Incyte
Seeking Alpha
Sat, 11/9/13 - 12:42 pm
Incyte
Geron's Promising News Poses No Threat To Incyte
Seeking Alpha
Fri, 11/8/13 - 11:59 am
Geron
Incyte
stem cells
imetelstat
Incyte Earnings Show Product and Pipeline Progress
Motley Fool
Fri, 11/1/13 - 04:47 pm
Incyte
earnings
Clovis, Synta, and Incyte Could Be Big Movers Today
Motley Fool
Tue, 10/29/13 - 09:42 am
Clovis Oncology
Synta
Incyte
CO-1686
non-small cell lung cancer
ganetespib
INCB39110
rheumatoid arthritis
Incyte Has First-Mover Advantage
Motley Fool
Wed, 10/2/13 - 10:10 am
Incyte
myelofibrosis
Jakafi
Novartis

Pages